Arscott Karen E, Eget Donna M, Marcos Maria C, Piper Brian J
Geisinger Commonwealth School of Medicine, Geisinger Health System, Scranton, PA, United States.
Medicus Urgent Care, Dunmore, PA, United States.
Front Psychiatry. 2024 Sep 20;15:1368598. doi: 10.3389/fpsyt.2024.1368598. eCollection 2024.
Substance Use Disorder (SUD) screening tools used in current practice are designed to identify SUD once patients have begun regular dangerous drug use. While these screening tools are valuable, prevention and avoidance of SUD would save countless lives. The climbing number of deaths due to drug overdose make screening for and prevention of SUD imperative. This study addresses this care gap. The aim was to develop a simple screening tool for patients who may be prone to develop Alcohol Use Disorder (AUD) and/or SUD prior to addiction. It was hypothesized that participants with initially positive emotional experiences would be correlated with a future SUD diagnosis.
The study involved a self-administered survey using a cross-sectional design and was carried out over one-month in the spring of 2021. Those patients who presented to the MAT clinic (SUD group) were seen in a separate area than the patients presenting for urgent care (Comparison group). Participants (N = 259) were voluntarily recruited from MAT and Urgent care: Patients receiving acute care were assigned to the Comparison (N = 126, 50.8% female, 5.7% non-white, 27.2% age < 34) and those receiving treatment for SUD were assigned to the MAT group (N =133, 40.8% female, 4.8% non-white, 36.8% ≤34). The survey questioned demographics (4 items), risk factors for AUD/SUD (6 items), information about first alcohol/opioid experiences (16 items), and factors for seeking AUD/SUD treatment and recovery (2 items). Feelings were categorized as positive (e.g., euphoria, happiness, self-confident), neutral (e.g., nothing, normal), or negative (e.g., depressed, sad, sick).
The MAT group felt more positive feelings with first usage of alcohol and opioids compared to the comparison group (p<.001). With first usage of opioids specifically, MAT (0.13 ± 0.04) and comparison (0.29 ± 0.07) groups differed (p <.001). Over half (55.3%), of the MAT participants reported feeling self-confident with first use of alcohol while only 29.7% of the comparison reported this (p<.001). Over three-fifths (63.7%) of the MAT group reported feeling of euphoria with the first usage of opioids compared to one-tenth (9.8%) in the comparison group (p<.001).
This retrospective cross-sectional report shows the first affective responses to substances may predict risk for future SUD and could be a prevention screening tool. Asking patients about positive feelings with first usage of alcohol/opioids could be a simple screening tool employed for prevention.
当前临床实践中使用的物质使用障碍(SUD)筛查工具旨在在患者开始经常使用危险药物后识别SUD。虽然这些筛查工具很有价值,但预防和避免SUD可以挽救无数生命。因药物过量导致的死亡人数不断攀升,使得对SUD的筛查和预防势在必行。本研究旨在填补这一护理空白。其目的是为可能在成瘾前易患酒精使用障碍(AUD)和/或SUD的患者开发一种简单的筛查工具。研究假设最初有积极情绪体验的参与者与未来的SUD诊断相关。
该研究采用横断面设计进行自我管理的调查,于2021年春季进行了一个月。那些前往药物辅助治疗诊所(SUD组)的患者与前来紧急护理的患者(对照组)在不同区域就诊。参与者(N = 259)从药物辅助治疗和紧急护理中自愿招募:接受急性护理的患者被分配到对照组(N = 126,50.8%为女性,5.7%为非白人,27.2%年龄<34岁),接受SUD治疗的患者被分配到药物辅助治疗组(N = 133,40.8%为女性,4.8%为非白人,36.8%≤34岁)。该调查询问了人口统计学信息(4项)、AUD/SUD的风险因素(6项)、首次饮酒/使用阿片类药物的经历信息(16项)以及寻求AUD/SUD治疗和康复的因素(2项)。情绪被分为积极(如欣快、快乐、自信)、中性(如无、正常)或消极(如抑郁、悲伤、不适)。
与对照组相比,药物辅助治疗组在首次使用酒精和阿片类药物时感觉更积极(p<.001)。特别是在首次使用阿片类药物时,药物辅助治疗组(0.13±0.04)和对照组(0.29±0.07)存在差异(p<.001)。超过一半(55.3%)的药物辅助治疗组参与者报告在首次使用酒精时感到自信,而对照组中只有29.7%的人报告有此感受(p<.001)。超过五分之三(63.7%)的药物辅助治疗组报告在首次使用阿片类药物时有欣快感,而对照组中只有十分之一(9.8%)的人报告有此感受(p<.001)。
这份回顾性横断面报告表明,对物质的首次情感反应可能预测未来SUD的风险,并且可能成为一种预防筛查工具。询问患者首次使用酒精/阿片类药物时的积极感受可能是一种用于预防的简单筛查工具。